The Alabama Department of Public Health observes Zero HIV Stigma Day, urging public support to end stigma and foster inclusivity as part of a national HIV initiative.

WHO recommends twice-yearly injectable lenacapavir for HIV prevention, expanding PrEP options for key populations.

For more than two decades, the global community has united to fight the HIV pandemic, achieving remarkable progress. New HIV transmissions and AIDS-related deaths have dropped significantly, and ...

Adults who switched from daily ART to long-acting cabotegravir-rilpivirine showed high levels of virologic suppression, high ...

A new kind of HIV prevention is making it easier for those at risk to stay protected, thanks to a twice-yearly injection now ...

PEPFAR was launched in 2003 to stop the spread of HIV in Africa. Now, although some funding remains for the program, many of ...

Monday announced that Gilead researchers and collaborators will present new Phase 3 Purpose trial data at IAS 2025 showing ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Gilead researchers and collaborators will present new Phase 3 ...

One way to cope with cuts in HIV prevention funding is to continue to push to increase the number of people who self-test for HIV instead of getting tested at a clinic or hospital, experts at a series ...

The Retention Riddle: Tackling the Toughest Barrier to Ending HIV: This session will explore proven strategies for ensuring people living with HIV stay connected to care and treatment services, a ...

8 July 2025 (Kigali, Rwanda) – IAS 2025, the 13th IAS Conference on HIV Science, taking place in Kigali, Rwanda, and virtually from 13 to 17 July, will feature an array of studies that address the ...